SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-23-018368
Filing Date
2023-09-21
Accepted
2023-09-21 11:25:39
Documents
7
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6175
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 534490
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 189262
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 5990
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6079
6 GRAPHIC exhibit99-1xu002.jpg GRAPHIC 16203
7 GRAPHIC exhibit99-2xu001.jpg GRAPHIC 15619
  Complete submission text file 0001062993-23-018368.txt   787382
Mailing Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9
Business Address SUITE 820, 1075 WEST GEORGIA STREET VANCOUVER A1 V6E 3N9 604-336-8613
C21 Investments Inc. (Filer) CIK: 0000831609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 000-55982 | Film No.: 231268289
SIC: 2833 Medicinal Chemicals & Botanical Products